Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Analysis of Efficacy Factors for Autologous Platelet-Rich Plasma Therapy in the Treatment of Elbow Tendinopathy
Sponsor: CHA University
Summary
To identify key factors influencing the effectiveness of platelet-rich plasma (PRP) therapy in treating elbow tendinopathy, a common degenerative condition.
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-02
Completion Date
2025-12
Last Updated
2025-02-07
Healthy Volunteers
No
Conditions
Interventions
Autologous Platelet-Rich Plasma (PRP) Injection
Participants will receive autologous PRP injections prepared from their own blood to treat elbow tendinopathy. PRP is a plasma product with a 3-5 times higher platelet concentration than normal blood, containing growth factors such as TGF-β, PDGF, IGF, and EGF, which are known to promote tissue repair and regeneration. The PRP will be injected directly into the affected tendon area to evaluate its clinical effectiveness and the relationship between platelet concentration, growth factors, and treatment outcomes.
Locations (1)
Bundang CHA Medical Center
Seongnam-si, Gyeonggi-do, South Korea